Brief: Inmed Provides Update On Baymedica Rare Cannabinoid Business
July 20 (Reuters) - InMed Pharmaceuticals Inc INM.O :
* INMED PROVIDES UPDATE ON BAYMEDICA RARE CANNABINOID
BUSINESS
* INMED PHARMACEUTICALS- EXPERIENCED REVENUE GROWTH FOR Q4
IN
BAYMEDICA SEGMENT, EXPECTS TO REPORT AN OVERALL NET LOSS FOR
YEAR ENDED JUNE 30, 2023
((Reuters.Briefs@thomsonreuters.com;))